Tracked deals
5
5 tracked deals across 2019-2021.
Operating Company
Healthcare
ELIQUENT Life Sciences
San Francisco, California, United States
Formerly known as Validant
ELIQUENT Life Sciences is a full-service regulatory consulting firm for life sciences innovators, providing regulatory, quality, and compliance answers and solutions across the product lifecycle to help clients gain and maintain market authorization.
- Focus Areas
- Regulatory Affairs Consulting, Quality & Compliance Implementation, Clinical Outcomes Assessment (COA)
- Website
- eliquent.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
4 addon · 1 buyout
ELIQUENT Life Sciences Acquisition Volume by Year
Last 3 years
Supporting Data
Recent Transactions
-
May 20, 2021
- Buyer
- Validant
- Target
- Clinical Outcomes Solutions
- Industry
- Healthcare Services
- Location
- United Kingdom
- Type
- Buyout
Validant has acquired Clinical Outcomes Solutions (COS), a UK‑headquartered specialist in clinical outcomes assessment (COA) and HEOR services with US offices in Tucson and Chicago. The acquisition expands Validant’s life‑sciences consulting capabilities by adding COS’s patient‑centered COA expertise to its global regulatory and quality services.
-
April 23, 2021
- Buyer
- Validant, GHO Capital Partners LLP
- Target
- Greenleaf Health, Inc.
- Industry
- Healthcare Services
- Location
- District of Columbia, United States
- Type
- Addon
Validant, a PE-backed global quality, compliance and regulatory consulting group, has acquired Greenleaf Health, a Washington, D.C.-based FDA regulatory consulting firm. Concurrent with the acquisition, Greenleaf founder Patrick Ronan was named CEO of Validant as the combined group expands its regulatory and quality capabilities supported by GHO Capital.
-
April 15, 2021
- Buyer
- Validant, GHO Capital Partners LLP
- Target
- Oriel STAT A MATRIX
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Type
- Addon
Validant, a transatlantic quality, compliance and regulatory consulting group and portfolio company of GHO Capital, has acquired Oriel STAT A MATRIX, a New Jersey–headquartered consultancy and training firm serving the medical device, IVD and combination product markets. The deal expands Validant’s capabilities into training services and deepens its regulatory consulting bench as part of an international add-on growth strategy.
-
December 2, 2020
- Buyer
- Validant, GHO Capital Partners LLP
- Target
- IDEC Inc.
- Industry
- Healthcare Services
- Location
- Tokyo, Japan
- Type
- Addon
Validant, a GHO Capital-backed quality, compliance and regulatory consulting group, has acquired IDEC, a Japan-based regulatory consultancy led by Naoya Kato. The acquisition gives Validant a Tokyo presence, expands its regulatory and implementation capabilities in Asia, and complements its earlier DataRevive acquisition to build a broader pan-Asian regulatory practice.
-
November 1, 2019
- Buyer
- Validant
- Target
- DataRevive
- Industry
- Healthcare Services
- Location
- District of Columbia, United States
- Type
- Addon
Validant, a transatlantic quality, compliance and regulatory consulting group backed by GHO Capital, has acquired DataRevive, a regulatory strategy and consulting firm focused on novel therapeutics and biologics. The deal expands Validant's capabilities in life‑science regulatory consulting and adds a Washington, D.C. location to its existing footprint in San Francisco, Research Triangle Park and Cork, Ireland.
Related Acquisition Pages
Selling a company? Get in front of buyers like ELIQUENT Life Sciences
Turn tracked acquisition activity into an outreach-ready buyer list.